Total Mesorectal Excision with or without Lateral Pelvic Lymph Node Dissection in Rectal Cancer.

IF 1.6 Q4 ONCOLOGY

International Journal of Surgical Oncology Pub Date : 2023-12-26 eCollection Date: 2023-01-01 DOI:10.1155/2023/6653624

Mohamed Yehia Elbarmelgi, Ahmed Mohamed Abdelaal, Osama Refaie, Mohamed Tamer, Ali Ahmed Shafik

{"title":"Total Mesorectal Excision with or without Lateral Pelvic Lymph Node Dissection in Rectal Cancer.","authors":"Mohamed Yehia Elbarmelgi, Ahmed Mohamed Abdelaal, Osama Refaie, Mohamed Tamer, Ali Ahmed Shafik","doi":"10.1155/2023/6653624","DOIUrl":null,"url":null,"abstract":"Results: Incidence of local recurrence was slightly higher in Group A (8.7%) than in Group B (4.3%) but was not statistically significant. There was no statistical significance between both groups regarding distant metastasis (8.7% in Group A and 13% in Group B). Urinary and sexual dysfunctions were higher in Group B (26.1%) compared to those in Group A (21.7%) but were not statistically significant. The incidence of lateral pelvic lymph node metastasis was 30.4%. Also, intraoperative blood loss was higher and operative time was longer in Group B which was statistically significant (P value <0.001).Conclusion: Our conclusion was that prophylactic addition of LPLD to TME was not associated with a statistically significant decrease in the risk of local recurrence or distant metastasis in patients with rectal cancer, although it was numerically better. LPLD is associated with longer operative time and higher intraoperative blood loss.","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2023 ","pages":"6653624"},"PeriodicalIF":1.6000,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10761226/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Surgical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2023/6653624","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Results: Incidence of local recurrence was slightly higher in Group A (8.7%) than in Group B (4.3%) but was not statistically significant. There was no statistical significance between both groups regarding distant metastasis (8.7% in Group A and 13% in Group B). Urinary and sexual dysfunctions were higher in Group B (26.1%) compared to those in Group A (21.7%) but were not statistically significant. The incidence of lateral pelvic lymph node metastasis was 30.4%. Also, intraoperative blood loss was higher and operative time was longer in Group B which was statistically significant (P value <0.001).

Conclusion: Our conclusion was that prophylactic addition of LPLD to TME was not associated with a statistically significant decrease in the risk of local recurrence or distant metastasis in patients with rectal cancer, although it was numerically better. LPLD is associated with longer operative time and higher intraoperative blood loss.

查看原文本刊更多论文

在直肠癌中进行全中胚层切除术，同时进行或不进行侧盆腔淋巴结清扫术

结果A 组的局部复发率（8.7%）略高于 B 组（4.3%），但无统计学意义。两组的远处转移率（A 组为 8.7%，B 组为 13%）无统计学意义。与 A 组（21.7%）相比，B 组的排尿和性功能障碍发生率更高（26.1%），但无统计学意义。盆腔侧淋巴结转移的发生率为 30.4%。此外，B 组的术中失血量更高，手术时间更长，差异有统计学意义（P 值结论）：我们的结论是，在 TME 中预防性增加 LPLD 并不能显著降低直肠癌患者的局部复发或远处转移风险，尽管在数量上更胜一筹。LPLD与更长的手术时间和更高的术中失血量有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Surgical Oncology ONCOLOGY-

CiteScore

3.70

自引率

0.00%

发文量

审稿时长

20 weeks

期刊介绍： International Journal of Surgical Oncology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies in all areas of surgical oncology.